The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction

Bibliographic Details
Main Authors: Pankaj Jariwala, Kartik Jadhav, Jagdish Madireddi, Anil Kulkarni, Kashyap Vyas, Arshad Punjani, Harikishan Boorougu, Dilip Babu Madhawar
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Indian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483220303345
id doaj-cdb27ae5889544b7a0e8042ae927d553
record_format Article
spelling doaj-cdb27ae5889544b7a0e8042ae927d5532020-12-07T04:14:15ZengElsevierIndian Heart Journal0019-48322020-11-0172S24The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fractionPankaj Jariwala0Kartik Jadhav1Jagdish Madireddi2Anil Kulkarni3Kashyap Vyas4Arshad Punjani5Harikishan Boorougu6Dilip Babu Madhawar7Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 IndiaDepartment of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 Indiahttp://www.sciencedirect.com/science/article/pii/S0019483220303345
collection DOAJ
language English
format Article
sources DOAJ
author Pankaj Jariwala
Kartik Jadhav
Jagdish Madireddi
Anil Kulkarni
Kashyap Vyas
Arshad Punjani
Harikishan Boorougu
Dilip Babu Madhawar
spellingShingle Pankaj Jariwala
Kartik Jadhav
Jagdish Madireddi
Anil Kulkarni
Kashyap Vyas
Arshad Punjani
Harikishan Boorougu
Dilip Babu Madhawar
The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
Indian Heart Journal
author_facet Pankaj Jariwala
Kartik Jadhav
Jagdish Madireddi
Anil Kulkarni
Kashyap Vyas
Arshad Punjani
Harikishan Boorougu
Dilip Babu Madhawar
author_sort Pankaj Jariwala
title The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
title_short The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
title_full The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
title_fullStr The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
title_full_unstemmed The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
title_sort addition of dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptor blocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reducedejection fraction
publisher Elsevier
series Indian Heart Journal
issn 0019-4832
publishDate 2020-11-01
url http://www.sciencedirect.com/science/article/pii/S0019483220303345
work_keys_str_mv AT pankajjariwala theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT kartikjadhav theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT jagdishmadireddi theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT anilkulkarni theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT kashyapvyas theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT arshadpunjani theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT harikishanboorougu theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT dilipbabumadhawar theadditionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT pankajjariwala additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT kartikjadhav additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT jagdishmadireddi additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT anilkulkarni additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT kashyapvyas additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT arshadpunjani additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT harikishanboorougu additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
AT dilipbabumadhawar additionofdapagliflozinsodiumglucosecotransporter2inhibitortoangiotensinreceptorblockerneprilysininhibitorsnonrespondersinpatientwithrefractoryheartfailurewithreducedejectionfraction
_version_ 1724398103458480128